| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,908 |
8,723 |
$1.00M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
9,584 |
7,789 |
$989K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,279 |
7,626 |
$977K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,403 |
1,311 |
$433K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
164 |
140 |
$324K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,862 |
4,384 |
$297K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,037 |
1,793 |
$215K |
| 71045 |
Radiologic examination, chest; single view |
1,439 |
1,121 |
$139K |
| 71046 |
Radiologic examination, chest; 2 views |
1,606 |
1,370 |
$135K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
26,354 |
20,407 |
$112K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,397 |
1,118 |
$107K |
| 80053 |
Comprehensive metabolic panel |
17,390 |
13,668 |
$91K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,037 |
2,188 |
$87K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
734 |
221 |
$77K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
453 |
378 |
$70K |
| 36415 |
Collection of venous blood by venipuncture |
30,973 |
22,226 |
$68K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
745 |
622 |
$67K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,152 |
881 |
$59K |
| G0378 |
Hospital observation service, per hour |
1,351 |
790 |
$55K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,250 |
1,174 |
$54K |
| 87581 |
|
1,417 |
1,324 |
$45K |
| 87486 |
|
1,417 |
1,324 |
$45K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,426 |
1,328 |
$40K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,281 |
1,085 |
$39K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,491 |
1,122 |
$38K |
| 70450 |
Computed tomography, head or brain; without contrast material |
435 |
368 |
$33K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
441 |
121 |
$30K |
| 84484 |
|
3,514 |
2,349 |
$25K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
600 |
486 |
$22K |
| 83735 |
|
4,772 |
3,931 |
$19K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,070 |
3,262 |
$18K |
| 83690 |
|
3,891 |
3,250 |
$13K |
| 87070 |
|
1,696 |
1,562 |
$13K |
| 80076 |
|
2,237 |
1,877 |
$12K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
554 |
483 |
$11K |
| 99310 |
Prolong nursin fac eval 15m |
839 |
489 |
$11K |
| 84443 |
Thyroid stimulating hormone (TSH) |
990 |
900 |
$10K |
| 82150 |
|
2,490 |
2,076 |
$10K |
| 81000 |
|
3,695 |
3,122 |
$8K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
284 |
263 |
$8K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
284 |
263 |
$8K |
| 80061 |
Lipid panel |
957 |
874 |
$7K |
| 83880 |
|
383 |
334 |
$7K |
| 84703 |
|
1,565 |
1,312 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,096 |
949 |
$4K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
376 |
290 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
636 |
570 |
$3K |
| 73630 |
|
80 |
54 |
$3K |
| 87040 |
|
789 |
370 |
$3K |
| 85379 |
|
435 |
382 |
$3K |
| 84550 |
|
828 |
704 |
$2K |
| 99306 |
Prolong nursin fac eval 15m |
130 |
78 |
$2K |
| 83605 |
|
478 |
286 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
168 |
151 |
$2K |
| 80306 |
|
234 |
202 |
$2K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
288 |
177 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
258 |
206 |
$2K |
| 85610 |
|
491 |
435 |
$2K |
| 82803 |
|
214 |
121 |
$1K |
| 81003 |
|
566 |
470 |
$1K |
| 81002 |
|
1,125 |
931 |
$1K |
| 85730 |
|
183 |
164 |
$1K |
| 87081 |
|
198 |
164 |
$586.05 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
16 |
13 |
$515.97 |
| 96376 |
|
409 |
173 |
$504.63 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
50 |
24 |
$417.06 |
| 80051 |
|
108 |
105 |
$376.87 |
| 86803 |
|
27 |
26 |
$371.02 |
| 84439 |
|
58 |
53 |
$354.67 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
17 |
13 |
$312.10 |
| 84702 |
|
29 |
26 |
$252.14 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
27 |
15 |
$239.90 |
| 86308 |
|
65 |
62 |
$224.25 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
12 |
12 |
$216.72 |
| 82607 |
|
12 |
12 |
$180.96 |
| 82565 |
|
68 |
65 |
$172.18 |
| 84520 |
|
87 |
84 |
$154.81 |
| 99223 |
Prolong inpt eval add15 m |
17 |
12 |
$146.98 |
| 82550 |
|
38 |
37 |
$129.06 |
| 86592 |
|
26 |
25 |
$98.21 |
| 87340 |
|
12 |
12 |
$92.97 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
21 |
14 |
$77.39 |
| 82947 |
|
72 |
69 |
$76.50 |
| 87186 |
|
105 |
93 |
$61.90 |
| 82570 |
|
114 |
103 |
$51.46 |
| 84460 |
|
12 |
12 |
$51.39 |
| 87205 |
|
13 |
13 |
$50.34 |
| 87641 |
|
14 |
13 |
$35.09 |
| 86140 |
|
43 |
41 |
$15.06 |
| A9270 |
Non-covered item or service |
556 |
432 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
28 |
25 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
13 |
12 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
23 |
12 |
$0.00 |
| 99233 |
Prolong inpt eval add15 m |
35 |
13 |
$0.00 |